1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Andersen, N.H. Cao, B. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 32 1407 1422 10.1021/bi00057a004 8431421 Hevein: NMR assignment and assessment of solution-state folding for the agglutinin-toxin motif. 1993 US Biochem.Biophys.Res.Commun. BBRCA9 0146 0006-291X 184 1008 Peptide(Slash)Protein Structure Analysis Using the Chemical Shift Index Method: Upfield Alpha-Ch Values Reveal Dynamic Helices and Alpha L Sites 1992 US Biochemistry BICHAW 0033 0006-2960 31 1280 Conformational Isomerism of Endothelin in Acidic Aqueous Media: A Quantitative Noesy Analysis 1992 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4731.166 HEVEIN 1 man polymer no no EQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKD EQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKD A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Hevea sample 3981 Hevea brasiliensis pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1994-01-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1993-01-14 REL 6 BRUNGER refinement X-PLOR GLU 1 n 1 GLU 1 A GLN 2 n 2 GLN 2 A CYS 3 n 3 CYS 3 A GLY 4 n 4 GLY 4 A ARG 5 n 5 ARG 5 A GLN 6 n 6 GLN 6 A ALA 7 n 7 ALA 7 A GLY 8 n 8 GLY 8 A GLY 9 n 9 GLY 9 A LYS 10 n 10 LYS 10 A LEU 11 n 11 LEU 11 A CYS 12 n 12 CYS 12 A PRO 13 n 13 PRO 13 A ASN 14 n 14 ASN 14 A ASN 15 n 15 ASN 15 A LEU 16 n 16 LEU 16 A CYS 17 n 17 CYS 17 A CYS 18 n 18 CYS 18 A SER 19 n 19 SER 19 A GLN 20 n 20 GLN 20 A TRP 21 n 21 TRP 21 A GLY 22 n 22 GLY 22 A TRP 23 n 23 TRP 23 A CYS 24 n 24 CYS 24 A GLY 25 n 25 GLY 25 A SER 26 n 26 SER 26 A THR 27 n 27 THR 27 A ASP 28 n 28 ASP 28 A GLU 29 n 29 GLU 29 A TYR 30 n 30 TYR 30 A CYS 31 n 31 CYS 31 A SER 32 n 32 SER 32 A PRO 33 n 33 PRO 33 A ASP 34 n 34 ASP 34 A HIS 35 n 35 HIS 35 A ASN 36 n 36 ASN 36 A CYS 37 n 37 CYS 37 A GLN 38 n 38 GLN 38 A SER 39 n 39 SER 39 A ASN 40 n 40 ASN 40 A CYS 41 n 41 CYS 41 A LYS 42 n 42 LYS 42 A ASP 43 n 43 ASP 43 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 5 0.259 SIDE CHAIN 2 A ARG 5 0.258 SIDE CHAIN 3 A ARG 5 0.306 SIDE CHAIN 4 A ARG 5 0.231 SIDE CHAIN 5 A ARG 5 0.259 SIDE CHAIN 6 A ARG 5 0.300 SIDE CHAIN 1 A A CG CD2 HIS HIS 35 35 0.058 0.009 1.354 1.412 N 2 A A CG CD2 HIS HIS 35 35 0.056 0.009 1.354 1.410 N 3 A A CG CD2 HIS HIS 35 35 0.058 0.009 1.354 1.412 N 4 A A CG CD2 HIS HIS 35 35 0.059 0.009 1.354 1.413 N 5 A A CG CD2 HIS HIS 35 35 0.058 0.009 1.354 1.412 N 6 A A CG CD2 HIS HIS 35 35 0.058 0.009 1.354 1.412 N 1 A GLN 6 -73.61 30.73 1 A ALA 7 -153.72 -5.43 1 A ASN 14 51.63 17.29 1 A LEU 16 -52.70 171.33 1 A SER 26 -119.23 61.30 1 A ASN 36 57.90 71.02 2 A GLN 6 -86.03 37.11 2 A ALA 7 -171.24 8.04 2 A ASN 14 -79.58 20.55 2 A SER 26 -116.49 63.35 3 A GLN 6 -85.17 33.19 3 A ALA 7 -162.12 -5.27 3 A ASN 14 -75.49 24.93 3 A TRP 21 -65.39 1.62 3 A SER 26 -114.93 61.40 3 A ASN 36 54.88 72.91 4 A CYS 3 -166.69 -164.36 4 A GLN 6 -95.23 39.89 4 A ALA 7 -172.70 1.23 5 A GLN 6 -73.61 30.73 5 A ALA 7 -153.72 -5.43 5 A ASN 14 51.63 17.29 5 A LEU 16 -52.70 171.33 5 A SER 26 -119.23 61.30 5 A ASN 36 57.90 71.02 6 A GLN 6 -85.44 33.63 6 A ALA 7 -162.18 14.14 6 A PRO 13 -63.13 20.77 6 A ASN 14 73.32 -9.85 6 A ASN 36 72.60 47.71 model building X-PLOR refinement X-PLOR phasing X-PLOR HEVEIN (NMR, 6 STRUCTURES) HEVEIN: THE NMR ASSIGNMENT AND AN ASSESSMENT OF SOLUTION-STATE FOLDING FOR THE AGGLUTININ-TOXIN MOTIF 1 Y N A ASP 28 A ASP 28 HELX_P A CYS 31 A CYS 31 1 A 4 A PRO 33 A PRO 33 HELX_P A HIS 35 A HIS 35 5 B 3 disulf 2.039 A CYS 3 A SG CYS 3 1_555 A CYS 18 A SG CYS 18 1_555 disulf 2.040 A CYS 12 A SG CYS 12 1_555 A CYS 24 A SG CYS 24 1_555 disulf 2.035 A CYS 17 A SG CYS 17 1_555 A CYS 31 A SG CYS 31 1_555 disulf 2.040 A CYS 37 A SG CYS 37 1_555 A CYS 41 A SG CYS 41 1_555 LECTIN LECTIN HEVE_HEVBR UNP 1 1 P02877 MNIFIVVLLCLTGVAIAEQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKDSGEGVGGGSASNVLATYHLY NSQDHGWDLNAASAYCSTWDANKPYSWRSKYGWTAFCGPVGAHGQSSCGKCLSVTNTGTGAKTTVRIVDQCSNGGLDLDV NVFRQLDTDGKGYERGHITVNYQFVDCGDSFNPLFSVMKSSVIN 18 60 1HEV 1 43 P02877 A 1 1 43 3 anti-parallel anti-parallel A TRP 23 A TRP 23 A SER 26 A SER 26 A LEU 16 A LEU 16 A SER 19 A SER 19 A GLN 38 A GLN 38 A ASN 40 A ASN 40 1 P 1